Applied Genetic Technologies
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
CHULAY JEFFREY D. officer: VP and Chief Medical O..
 Stock Option (Right to Buy) 2,277 $3.5 $7,970
Option
CHULAY JEFFREY D. officer: VP and Chief Medical O..
 Common Stock 2,277 $3.5 $7,970
Purchase
MEDIMMUNE VENTURES, INC. 10 percent owner
 Common Stock 75,735 $12 $908,820
Purchase
GLAXOSMITHKLINE PLC other: Former 10% Owner
 Common Stock 103,762 $12 $1,245,144
Purchase
WU SAMUEL director, 10 percent owner
 Common Stock 75,735 $12 $908,820
Purchase
CARROLL JILL director, 10 percent owner
 Common Stock 103,762 $12 $1,245,144
Purchase
ORONSKY ARNOLD L director
 Common Stock 75,736 $12 $908,832
Purchase
ROSEN JAMES director
 Common Stock 62,871 $12 $754,452
Purchase
INTERWEST PARTNERS VIII LP 10 percent owner
 Common Stock 75,376 $12 $904,512
Purchase
ALTA PARTNERS VIII, L.P. 10 percent owner
 Common Stock 155,645 $12 $1,867,740

Showing 50 to 60 of 60 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: